---
title: "CVS Stock Approaches Q4 Earnings With Resistance In Sight"
date: "2025-02-12 03:16:14"
summary: "CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside. CVS currently trading at $54.22."
categories:
  - "benzinga"
lang:
  - "en"
translations:
  - "en"
tags:
  - "benzinga"
menu: ""
thumbnail: "https://www.benzinga.com/files/images/story/2025/02/11/CVS-Health-Corp--CVS.jpeg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside. CVS currently trading at $54.22.

[benzinga](https://www.benzinga.com/general/health-care/25/02/43636486/cvs-stock-approaches-q4-earnings-with-resistance-in-sight)
